Increasing local investment and expanding production capacity to meet global growing market demand for high-performance medical-grade materials.
Establishing the “Lubrizol Center of Excellence for High-Performance Films” to accelerate innovation in advanced medical film applications and propel industry advancement, for local and global markets.

Shanghai, China - September 22, 2025 - Lubrizol, a global leader in specialty chemicals, announced two key initiatives to strengthen its long-term commitment to China's Medical industry. Lubrizol is actively expanding the local production capacity for medical-grade thermoplastic polyurethane (TPU) and has established the Lubrizol Center of Excellence for High-Performance Films. By making these strategic investments, Lubrizol deepens its focus on innovation-driven growth, localization, and collaborative development, while further demonstrating its dedication to supporting global markets and meeting the evolving needs of customers. These commitments directly address the rising demand for high-quality medical materials in China and will accelerate the development and commercialization of advanced medical film technologies.

“The expansion of our local capacity and the establishment of our Center of Excellence mark important milestones in Lubrizol’s ongoing efforts to deepen our presence in the local market and strengthen regional industry collaboration,” said Henry Liu, Vice President of Lubrizol Asia Pacific. “We are committed not only to providing customers and partners with faster responsiveness, more reliable supply chain assurance, and higher-value solutions, but also to integrating our global material science expertise with local needs—empowering customers to accelerate innovation and working together to build a more efficient and sustainable healthcare ecosystem.”

John Valukas, Senior Vice President and President of Lubrizol Engineered Polymers, added: “Innovation has always been central to Lubrizol’s mission. With decades of technical expertise and a strong track record in medical-grade TPU applications worldwide, we are proud to be at the forefront of industry advancement. Expanding our local production capacity and establishing the new Center of Excellence in China combine our global strengths with local capabilities. This allows us to respond quickly to the diverse needs of China’s medical sector, deliver greater value to our customers and partners, and ultimately improve patient outcomes.”

Increasing Local Investment to Enhance Supply Chain Resilience and Responsiveness

Lubrizol is expanding its medical-grade TPU manufacturing portfolio at its Shanghai Songjiang facility to address the growing demand for premium-quality medical materials in China and beyond. The expansion not only adds new momentum to Lubrizol's existing local medical portfolio but also significantly improves responsiveness and supply chain reliability for customers across Asia Pacific. Leveraging the advantages of Lubrizol's global manufacturing network, the upgraded local capacity provides dual benefits of localized service and global collaboration. This positions Lubrizol to not only support domestic growth but also to help Chinese medical device brands expand internationally with stronger supply assurance.

Establishing a Center of Excellence to Drive Local Innovation and Accelerate Commercialization

The newly established Lubrizol Center of Excellence for High-Performance Films integrates Lubrizol's global material science capabilities with localized application development, creating a dynamic innovation platform. With comprehensive capabilities in TPU formulation, processing, and testing, the Center will support multiple industries, with a strong focus on medical applications. Beyond advancing innovations in dental films, the Center is expanding into next-generation medical film applications, helping customers accelerate R&D, enhance local innovation efficiency, and push the boundaries of medical material applications.

Para obtener más información, visite nuestro sitio web en: https://www.lubrizol.com/industries/healthcare/medical

_start="ZH-CN"

加强本地投资，提升生产能力，积极响应本土及全球市场对高品质医用材料日益增长的需求。
建立“路博润高性能膜品技术卓越中心”，助力先进医疗膜品应用创新加速落地，推动行业高质量发展，服务中国及全球市场。

中国上海 —— 全球领先的特种化学品公司路博润宣布，将围绕本地化生产和技术创新两大核心支柱，持续加大在中国本地投资，进一步提升医用级热塑性聚氨酯（TPU）的生产和研发能力，并正式成立“路博润高性能膜品技术卓越中心”。两大举措进一步强化了路博润“以创新为引擎，本地化为根基，协同共进为路径” 的战略布局，充分展现了其服务全球市场、满足客户不断变化需求的坚定承诺。路博润积极响应中国医疗健康市场对高质量医用材料的持续增长需求，助力先进医疗膜品应用创新加速落地，推动行业实现高质量发展。

路博润亚太区副总裁刘茂树表示：“本地化产能的提升和技术卓越中心的建立，是路博润深耕本地市场、强化区域产业协同的重要里程碑。我们不仅能为客户和合作伙伴带来更快速的响应、更可靠的供应链保障和更具价值的解决方案，更致力于将全球材料科技优势与本土需求深度融合，助力客户加速创新，共同构建高效、可持续的生态系统。”

路博润高级副总裁兼工程材料业务总裁John Valukas表示：“创新始终是路博润的核心驱动力。我们在医用级热塑性聚氨酯（TPU）领域积累了丰富的技术实力和全球范围的应用能力，并不断推动行业进步。此次在中国扩展产能及成立技术卓越中心，生动诠释了本土与全球、生产与创新的深度协同。这不仅让我们能够快速响应中国医疗市场的多元需求，也为客户和合作伙伴创造更大价值, 并最终惠及广大患者，升级医疗体验。”

加码本地投资，增强供应链韧性与响应能力

为满足中国及全球医疗市场对高品质医用材料日益增长的需求，路博润在上海松江生产基地完成了战略布局，进一步扩大了医用级TPU产品的本土化制造品类。此次产能扩充不仅为现有本地医用级产品矩阵注入新动能，也显著提升了对亚太客户需求的响应速度与供应链的可靠性和灵活性。同时，依托路博润全球生产制造网络的协同优势，本土产能升级实现了“本土服务与全球协同”的双重效能。公司既能有力支持国内市场的持续增长，还可灵活助力客户拓展海外业务，为中国医疗器械品牌的“出海“ 提供了坚实保障。

打造技术卓越中心，驱动本土创新加速落地

路博润技术卓越中心深度融合了全球领先的材料科学实力与本地化应用开发能力，成为高性能膜品应用领域的重要创新平台。中心面向多个行业，具备从热塑性聚氨酯（TPU）配方设计与开发、加工工艺到终端性能测试的全流程能力。针对医疗领域，技术卓越中心不仅专注于牙科膜材的创新应用，更积极拓展多元前沿医用膜品领域，助力客户加速产品研发，提升本土创新效率，拓宽医疗材料的应用边界。

关于路博润公司

路博润公司是伯克希尔·哈撒韦公司（Berkshire Hathaway）旗下的一家特种化学品公司，致力于提供可持续解决方案，推动出行方式的进步，改善人类福祉，提升现代生活品质。每一天，路博润的创新者们以科学探索为基石，紧密围绕市场需求，以商业成功为指引，不断为客户创造卓越的价值。公司通过推动新发现和创造突破性的解决方案，改善人民的生活水平，让世界变得更美好。路博润成立于1928年，在全球设有生产基地、销售及技术办公室，员工近7000人，客户遍及100个国家和地区。了解更多信息，请访问www.Lubrizol.com。

_end

Lubrizol Strengthens Localization Strategy to Drive High-Quality Development in China’s Medical Industry, and Beyond